References
1. Rotunda AM, Rao J, Goldman M. Treatments for cellulite. In Lasers and Lights, Volume II, 2nd Edition. Goldberg D, Ed; Elsevier 2007.
2. Wollina U, Goldman A, Berger U, bdel-Naser MB. Esthetic and cosmetic dermatology. Dermatol Ther. 2008 Mar;21(2):118-30.
3. Querleux B, Cornillon C, Jolivet O, Bittoun J. Anatomy and physiology of subcutaneous adipose tissue by in vivo magnetic resonance imaging and spectroscopy: relationships with sex and presence of cellulite. Skin Res Technol. 2002 May;8(2):118-24.
4. Nurnberger F, Muller G. So-called cellulite: an invented disease. J Dermatol Surg Oncol. 1978 Mar;4(3):221-9.
5. Stewart PM, Tomlinson JW. Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity. Trends Endocrinol Metab. 2002 Apr;13(3):94-6.
6. Draelos ZD. The disease of cellulite. J Cosmet Dermatol. 2005;4:221-2.
7. Avram MM. Cellulite: a review of its physiology and treatment. J Cosmet Laser Ther. 2004 Dec;6(4):181-5.
8. Pavicic T, Borelli C, Korting HC. Cellulite—the greatest skin problem in healthy people? An approach. J Dtsch Dermatol Ges. 2006 Oct;4(10):861-70.
9. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care. 2001 Nov;4(6):499-502.
10. Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF. Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2. Metabolism. 1991 Sep;40(9):990-6.
11. Rasmussen BB, Wolfe RR. Regulation of fatty acid oxidation in skeletal muscle. Annu Rev Nutr. 1999;19:463-84.
12. SEPPIC. Data on file. 2008.
13. Quinkler M, Oelkers W, Diederich S. Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissues. Eur J Endocrinol. 2001 Feb;144(2):87-97.
14. Stewart PM, Krozowski ZS. 11 beta-Hydroxysteroid dehydrogenase. Vitam Horm. 1999;57:249-324.
15. Armanini D, Nacamulli D, Francini-Pesenti F, et al. Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application. Steroids. 2005 Jul;70(8):538-42.
16. Armanini D, Mattarello MJ, Fiore C, et al. Licorice reduces serum testosterone in healthy women. Steroids. 2004 Oct;69(11-12):763-6.
17. Nam C, Kim S, Sim Y, Chang I. Anti-acne effects of Oriental herb extracts: a novel screening method to select anti-acne agents.
Skin Pharmacol Appl Skin Physiol. 2003 Mar;16(2):84-90.
18. Friis-Moller A, Chen M, Fuursted K, Christensen SB, Kharazmi A. In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots. Planta Med. 2002 May;68(5):416-9.
19. Anon. Glycyrrhiza glabra. Monograph. Altern Med Rev. 2005 Sep;10(3):230-7.
20. Okimasu E, Moromizato Y, Watanabe S, et al. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Med Okayama. 1983 Oct;37(5):385-91.
21. Shibata S, Inoue H, Iwata S, et al. Inhibitory effects of licochalcone A isolated from Glycyrrhiza inflata root on inflammatory ear edema and tumour promotion in mice. Planta Med. 1991 Jun;57(3):221-4.
22. Abe K, Ikeda T, Wake K, et al. Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice. J Pharm Pharmacol. 2008 Jan;60(1):91-7.
23. Sato I, Kofujita H, Suzuki T, Kobayashi H, Tsuda S. Antiinflammatory effect of Japanese horse chestnut (Aesculus turbinata) seeds. J Vet Med Sci. 2006 May;68(5):487-9.
24. Guillaume M, Padioleau F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittelforschung. 1994 Jan;44(1):25-35.
25. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev. 2006;(1):CD003230.
26. Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review. Arch Dermatol. 1998 Nov;134(11):1356-60.
27. Bisler H, Pfeifer R, Kluken N, Pauschinger P. Effects of horse-chestnut seed extract on transcapillary filtration in chronic venous insufficiency. Dtsch Med Wochenschr. 1986 Aug 29;111(35):1321-9.
28. Diehm C, Trampisch HJ, Lange S, Schmidt C. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet. 1996 Feb 3;347(8997):292-4.
29. Sato I, Suzuki T, Kobayashi H, Tsuda S. Antioxidative and antigenotoxic effects of Japanese horse chestnut (Aesculus turbinata) seeds. J Vet Med Sci. 2005 Jul;67(7):731-4.
30. Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Arch Pharm (Weinheim). 1995 Oct;328(10):720-4.
31. Sirtori CR. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res. 2001 Sep;44(3):183-93.
32. Fujimura T, Tsukahara K, Moriwaki S, et al. A horse chestnut extract, which induces contraction forces in fibroblasts, is a potent anti-aging ingredient. J Cosmet Sci. 2006 Sep;57(5):369-76.
33. Ortonne JP, Zartarian M, Verschoore M, Queille-Roussel C, Duteil L. Cellulite and skin ageing: is there any interaction? J Eur Acad Dermatol Venereol. 2008 Feb 25.
34. Calabrese C, Preston P. Report of the results of a double-blind, randomized, single-dose trial of a topical 2% escin gel versus placebo in the acute treatment of experimentally-induced hematoma in volunteers. Planta Med. 1993 Oct;59(5):394-7.
35. Anon. Centella asiatica. Altern Med Rev. 2007 Mar;12(1):69-72.
36. Lee J, Jung E, Kim Y, et al. Asiaticoside induces human collagen I synthesis through TGFbeta receptor I kinase (TbetaRI kinase)-independent Smad signaling. Planta Med. 2006 Mar;72(4):324-8.
37. Hachem A, Borgoin JY. Eude anatomo-clinique des effects de e'extrait titre de centela asiatica dans la lipodystrophie localisse. LA Med Prat. 12 (Suppl 2): 17-21.
38. Martelli, Berardesca. Topical formulation of a new plant extract complex with refirming properties. Clinical and non-invasive evaluation in a double-blind trial. Int J Cos Sci. 2000 Jun;22(3):201-6.
39. Cesarone MR, Incandela L, De Sanctis MT, et al. Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella asiatica: a clinical prospective randomized trial with a microcirculatory model. Angiology. 2001 Oct;52 Suppl 2S49-S54.
40. Klovekorn W, Tepe A, Danesch U. A randomized, double-blind, vehicle-controlled, half-side comparison with a herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica for the treatment of mild-to-moderate atopic dermatitis. Int J Clin Pharmacol Ther. 2007 Nov;45(11):583-91.